| PHARMWORKS | ||
|
Home |
Pepin’s Pharmaceutical Prattle for XX-XX-2006
Quote of the day: Perseverance is more prevailing than violence; and many things which cannot be overcome when they are together, yield themselves up when taken little by little. Plutarch (46 AD - 120 AD)
Good morning !
Big Buns =================================================== ps. Best answer this week to the question "How are you?" was "Fantasticl" clerk at the super (fantastic) market. pps. Occasionally, some of the links require FREE registration.... I'm sure you can handle THAT slight inconvenience. ------------
1) Sweet Juanita …Diabetes drug approved FDA approved Januvia (sitagliptin) for use against type 2 (AKA adult onset) diabetes in addition to (you guessed it) diet and exercise. It may be added to other oral antidiabetic drugs or used as a single agent. I wonder if the drug company will wait until the first of January to launch it (Jan- January plus nuvia-novo-new)……{just a thought}. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01492.html
2) Bad news travels fast…and affects physicians' practices Two negative articles about a drug in major journals dropped the use of one drug from 16.6% to 5.6% in 10 months. It appears that doctors are reading and that they are quick to eliminated drugs that they perceive to be risky. They are slower to adopt new drugs or practices even with more and better data. I think that they feel that they are more likely to be sued for using a drug show to have higher risks that failure to use new drugs … before all is know about them. http://www.forbes.com/forbeslife/health/feeds/hscout/2006/10/17/hscout535555.html
3) FDA reaping what it sows. FDA eyes user fees on generic drugs as a way to increase revenue. With fewer new drug entities coming to market their source of money is slowing. As the clamour for more generics increases and generic approvals accelerate they need to fund the resources necessary to meet demands. http://www.boston.com/business/healthcare/articles/2006/10/18/fda_mulls_user_fees_for_generic_drugs/
4) Wal-Mart ponys up $4 generics in 14 more states After last weeks article about Medco's program for generics Wal-Mart rolls out their existing program to more states. http://www.washingtonpost.com/wp-dyn/content/article/2006/10/19/AR2006101901386.html
5) Seniors experience more adverse drug reactions that younger patients … but then again…. younger patients are usually healthier and take fewer drugs. Insulin, warfarin and amoxicillin were the top culprits. (one time I found that my father was taking two prescriptions together "Coumadin for my heart" and "Warfarin to thin my blood"…. no one bothered to tell him that they were the same thing and he was doubling his intake and risk of adverse consequences. http://jama.ama-assn.org/cgi/content/abstract/296/15/1858 (the JAMA itself)
6) Alzheimer's and Atypical antipsychotics It appears that atypical antipsychotic drugs do not help patients with Alzheimer's any better than placeobo (although placebo had fewer unacceptable side effects). This calls into question the use of these expensive drugs to treat psychosis, aggression, and agitation. Haldol and lorazepam may be best afterall. http://content.nejm.org/cgi/content/short/355/15/1525
7) New Part-D site now available to help patients select a plan Perported to be easier and faster than last year. Click the link and try for yourselves. (Or have you patients do it!)
Have a SUPER-FANTASTIC week. Steve
Disclaimer: "Pepin's Pharmaceutical Prattle" (AKA "The Prattle") is the property of PHARMWORKS, LLC and Steven M. Pepin, Pharm. D, BCPS. The opinions expressed are those of the bald-headed author. To start or stop any drug without the advice and supervision of your physician would be stupid. So don't do anything based upon what you read here without professional advice. To be added to or removed from the distribution list please e-mail your request to spepin@pharmworks.com . All insightful comments from readers are thoughtfully considered (the rest are callously discarded). Copyright 1998-2006 PHARMWORKS, LLC all rights reserved. --------------------------------------------------------------------------------------------------------------------------------------------------------------------
Copyright 1998-2006 PHARMWORKS.LLC all rights reserved |